Advertisement.

FGEN Projected Dividend Yield

FibroGen Inc ( NASDAQ : FGEN )

FibroGen, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapeutics for cancer and anemia. Co.'s pipeline includes Pamrevlumab, a first-in-class antibody targeting connective tissue growth factor (CTGF), in Phase III trials for locally advanced unresectable pancreatic cancer and Phase 2/3 for metastatic pancreatic cancer. Another key product, Roxadustat, is an oral HIF-PH inhibitor that promotes red blood cell production. FibroGen also develops FG-3165 (Anti-Gal9 Antibody) and FG-3175 (Anti-CCR8 Antibody).

21 YEAR PERFORMANCE RESULTS

FGEN Dividend History Detail
FGEN Dividend News
FGEN Competitors News

# of Shares: 0

Closing Price: 0.29

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000